These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7043979)

  • 21. [Antibody dynamics of carnivorous mammals and corvine birds infected with Francisella tularensis].
    Sukhanov NA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):105-8. PubMed ID: 6741361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Francisella tularensis Infection of Mice as a Model of Sepsis.
    Spencer CT; Ramos Muniz MG; Setzu NR; Sanchez Guillen MA
    Methods Mol Biol; 2021; 2321():75-100. PubMed ID: 34048009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of low-molecular-weight antioxidants in Francisella tularensis infected hosts: comparison of two rodents with different susceptibility to tularemia.
    Pohanka M; Bandouchova H; Novotny L; Pavlis O; Treml F; Sedlackova J; Pikula J
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():186-91. PubMed ID: 20027169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance.
    Anthony LS; Kongshavn PA
    Microb Pathog; 1987 Jan; 2(1):3-14. PubMed ID: 3507552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Environmental Monitoring and Surveillance of Rodents and Vectors for Francisella tularensis Following Outbreaks of Human Tularemia in Georgia.
    Elashvili E; Kracalik I; Burjanadze I; Datukishvili S; Chanturia G; Tsertsvadze N; Beridze L; Shavishvili M; Dzneladze A; Grdzelidze M; Imnadze P; Pearson A; Blackburn JK
    Vector Borne Zoonotic Dis; 2015 Oct; 15(10):633-6. PubMed ID: 26394283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contributions of TolC Orthologs to
    Kopping EJ; Doyle CR; Sampath V; Thanassi DG
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670554
    [No Abstract]   [Full Text] [Related]  

  • 28. [The epizootic characteristics of tularemia in the Crimea].
    Alekseev AF; Chirniĭ VI; Bogatyreva LM; Tovpinets NN; Evstaf'ev IL; Markeshin SIa; Kovin VV; Evstratov IuV; Zakharova TF; Galushko VI
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (6):28-32. PubMed ID: 9103072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nature of protective immunity to Francisella tularensis.
    Tärnvik A
    Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of coinfection with Francisella tularensis in reservoir animals of Borrelia burgdorferi sensu lato.
    Výrosteková V; Khanakah G; Kocianová E; Gurycová D; Stanek G
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):482-8. PubMed ID: 12422587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virulence comparison in mice of distinct isolates of type A Francisella tularensis.
    Twine SM; Shen H; Kelly JF; Chen W; Sjöstedt A; Conlan JW
    Microb Pathog; 2006 Mar; 40(3):133-8. PubMed ID: 16448801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed presence of alternatively activated macrophages during a Francisella tularensis infection.
    D'Elia RV; Laws TR; Núñez A; Taylor C; Clark GC
    Microb Pathog; 2015 Jan; 78():37-42. PubMed ID: 25284816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tularemia, "volume" two].
    Macela A
    Epidemiol Mikrobiol Imunol; 1998 Aug; 47(3):103-20. PubMed ID: 9748768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enigmatic resistance of sheep (Ovis aries) to infection by virulent Francisella tularensis.
    Bell JF; Wikel SK; Hawkins WW; Owen CR
    Can J Comp Med; 1978 Jul; 42(3):310-5. PubMed ID: 688073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tularemia (
    Cherry CC; Kwit NA; Ohms RE; Hammesfahr AM; Pappert R; Petersen JM; Nelson CA; Buttke DE
    J Wildl Dis; 2019 Oct; 55(4):944-946. PubMed ID: 30920904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of a serological micromethod for the detection of antibodies against Francisella tularensis].
    Nunes MP; Ricciardi ID
    An Microbiol (Rio J); 1980; 25():61-7. PubMed ID: 6982628
    [No Abstract]   [Full Text] [Related]  

  • 38. Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica.
    Stenmark S; Lindgren H; Tärnvik A; Sjöstedt A
    Microb Pathog; 2003 Aug; 35(2):73-80. PubMed ID: 12901846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental infection of five species of raptors and of hooded crows with Francisella tularensis biovar palaearctica.
    Mörner T; Mattsson R
    J Wildl Dis; 1988 Jan; 24(1):15-21. PubMed ID: 3280839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific recognition of the major capsid protein of Acanthamoeba polyphaga mimivirus by sera of patients infected by Francisella tularensis.
    Pelletier N; Raoult D; La Scola B
    FEMS Microbiol Lett; 2009 Aug; 297(1):117-23. PubMed ID: 19538509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.